Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 113Lymphoma 101Leukemia, Myeloid, Acute 94Myelodysplastic Syndromes 88Lymphoma, Non-Hodgkin 87Leukemia 86Hodgkin Disease 75Leukemia, Lymphocytic, Chronic, B-Cell 70Multiple Myeloma 57Lymphoma, Large B-Cell, Diffuse 57Lymphoma, Follicular 52Lymphoma, Mantle-Cell 48Burkitt Lymphoma 47Lymphoma, B-Cell, Marginal Zone 45Leukemia, Myeloid, Chronic-Phase 45Lymphoma, Large-Cell, Immunoblastic 44Leukemia, Myeloid, Accelerated Phase 43Myeloproliferative Disorders 42Congenital Abnormalities 42Leukemia, Myelomonocytic, Chronic 40Neoplasms, Plasma Cell 39Blast Crisis 38Recurrence 32Dendritic Cell Sarcoma, Interdigitating 32Primary Myelofibrosis 29Anemia, Refractory, with Excess of Blasts 29Myelodysplastic-Myeloproliferative Diseases 26Lymphoma, T-Cell, Cutaneous 26Leukemia, Myelogenous, Chronic, BCR-ABL Positive 26Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 24

Interventions

fludarabine phosphate 1fludarabine 1Whole-Body Irradiation 1Thiotepa 1Tacrolimus 1Methotrexate 1Cyclophosphamide 1Busulfan 1Bone Marrow Transplantation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
GATA2 Deficiency × Busulfan × Lymphoid × Clear all
NCT03779854 2026-05-14

Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant

Fred Hutchinson Cancer Center

Phase 2 Recruiting
68 enrolled
LymphoidMyeloidOther hematologic neoplasm

GATA2 Deficiency, Blastic Plasmacytoid Dendritic Cell Neoplasm, Burkitt Lymphoma, Leukemia, Mast-Cell, Leukemia, Myeloid, Myeloproliferative Disorders, Leukemia, Biphenotypic, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡